Dr. Miele Cosmed Group S.A. carries a market capitalization of 205.87M, placing it among publicly traded companies globally. Its enterprise value stands at 296.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 205.87M |
| Enterprise Value | 296.62M |
Dr. Miele Cosmed Group S.A. currently has 85.78M shares outstanding.
| Shares Outstanding | 85.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Dr. Miele Cosmed Group S.A. trades at a trailing price-to-earnings ratio of 14.53. The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 2.45.
| PE Ratio | 14.53 |
| PS Ratio | 0.47 |
| PB Ratio | 2.45 |
| P/TBV Ratio | 1.57 |
| P/FCF Ratio | 3.85 |
| P/OCF Ratio | 6.77 |
On an enterprise value basis, Dr. Miele Cosmed Group S.A. trades at an EV/EBITDA multiple of 12.66 and an EV/FCF ratio of 4.64. The EV/Sales ratio of 0.59 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.66 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.59 |
| EV / EBITDA | 12.66 |
| EV / EBIT | 12.66 |
| EV / FCF | 4.64 |
Dr. Miele Cosmed Group S.A. maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.82, indicating elevated leverage, while an interest coverage ratio of 6.71 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.98 |
| Quick Ratio | 0.03 |
| Debt / Equity | 23.82 |
| Debt / EBITDA | 2.79 |
| Interest Coverage | 6.71 |
Dr. Miele Cosmed Group S.A. posts a return on equity of 16.19 and a return on invested capital of 5.33.
| Return on Equity (ROE) | 16.19 |
| Return on Assets (ROA) | 3.75 |
| Return on Invested Capital (ROIC) | 5.33 |
| Return on Capital Employed (ROCE) | 11.38 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.38 |
Over the trailing twelve months, Dr. Miele Cosmed Group S.A. has paid 5.10M in income taxes, reflecting an effective tax rate of 23.90.
| Income Tax | 5.10M |
| Effective Tax Rate | 23.90 |
Dr. Miele Cosmed Group S.A.'s stock has declined approximately -36.50794% over the past 52 weeks. The 50-day moving average sits at 2.27, while the 200-day moving average is 2.77.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.50794% |
| 50-Day Moving Average | 2.27 |
| 200-Day Moving Average | 2.77 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Dr. Miele Cosmed Group S.A. generated 499.56M in revenue and converted that into 16.23M in net income, yielding earnings per share of 0.19. EBITDA reached 23.44M, while operating income came in at 23.44M.
| Revenue | 499.56M |
| Gross Profit | 212.57M |
| Operating Income | 23.44M |
| Pretax Income | 21.33M |
| Net Income | 16.23M |
| EBITDA | 23.44M |
| EBIT | 23.44M |
| Earnings Per Share (EPS) | 0.19 |
Dr. Miele Cosmed Group S.A. holds 4.70M in cash and equivalents against 65.43M in total debt, resulting in a net debt position of 46.67M. Total book value stands at 96.36M, with working capital of -2.16M providing operational flexibility.
| Cash & Cash Equivalents | 4.70M |
| Total Debt | 65.43M |
| Net Debt | 46.67M |
| Equity (Book Value) | 96.36M |
| Book Value Per Share | 1.12 |
| Working Capital | -2.16M |
Dr. Miele Cosmed Group S.A. produced 34.84M in operating cash flow over the past twelve months. After subtracting -26.49M in capital expenditures, free cash flow totaled 8.35M - equivalent to 0.10 per share.
| Operating Cash Flow | 34.84M |
| Capital Expenditures | -26.49M |
| Free Cash Flow | 8.35M |
| FCF Per Share | 0.10 |
Dr. Miele Cosmed Group S.A. operates with a gross margin of 42.55, reflecting its pricing power and cost economics. The operating margin of 4.69 and net profit margin of 3.25 provide insight into operational efficiency.
| Gross Margin | 42.55 |
| Operating Margin | 4.69 |
| Pretax Margin | 4.27 |
| Profit Margin | 3.25 |
| EBITDA Margin | 4.69 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 6.51 |
| FCF Yield | 26.00 |
Dr. Miele Cosmed Group S.A. posts an Altman Z-Score of 2.70, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.70 |